Back to search results

ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)

Abroad (travel likely)RecruitingPHASE2

Conditions

Pulmonary Tuberculosis (TB)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • National Tuberculosis and Leprosy Training Centre, Saye, Zaria, Kaduna State, Nigeria

    Contact: Study coordinator (Eunice N Jiya - Chitumu, MD) · +2348033714310
    Eunice Jiya, MD (Sub-investigator)

  • Federal Teaching Hospital, Katsina, Katsina State, Nigeria

    Contact: Study coordinator (Taofeek Oloyede, MD) · +2348029423132
    Taofeek Oloyede, MD (Sub-investigator)

  • Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Osun state, Nigeria, Ile-Ife, Osun State, Nigeria

    Contact: Study coordinator (Olanisun O Adewole, MD) · adewolef@yahoo.co.uk , ola.adewole@oauife.edu.ng · +2348034074930
    Contact: Study coordinator (Bolanle A Omotoso, MD) · bolamotee@yahoo.co.uk · +2347037350229
    Contact: Principal Investigator (Olanisun O Adewole, MD)
    Bolanle A Omotoso, MD (Sub-investigator)
    Olayemi F Awopeju, MD (Sub-investigator)
    Olugbenga Ayoola, MD (Sub-investigator)
Study leads

  • Olanisun O Adewole, MD

    Principal Investigator

    Obafemi Awolowo University / Teaching Hospital, Ile Ife, Nigeria

  • Bolanle A Omotoso, MD

    Study Director

    Obafemi Awolowo University /Teaching Hospital, Ile- Ife, Osun State, Nigeria

  • Olanisun O Adewole, MD

    Study Chair

    Obafemi Awolowo University /Teaching Hospital, Ile- Ife, Osun State, Nigeria

View source on ClinicalTrials.gov(opens in a new tab)